trx-0237 dihydrobromide

Hydromethylthionine, also known as LMTM and Leucomethylene Blue, is a apotent tau aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia. Hydromethylthionine showed pharmacological activity on brain structure and function as both monotherapy and as an add-on to symptomatic treatment in certain patients with Alzheimer’s disease.

Hydromethylthionine (Leukomethylene blue) 是一种具有非常活跃光化学特性的试剂，尤其是在与溶解氧的交互中。其光化学活性主要通过三重态与溶解氧的反应调节。在紫外线照射下，Hydromethylthionine 的三重态会与溶解氧反应，生成 Methylene Blue 和水合氢离子。它可用于半导体光催化中模型污染物的光降解以及化学分析中的指示剂研究。